cbdMD Inc YCBD

US Pharmaceuticals
$0.51 โ–ฒ +7.62% (+$0.04)
⬆️ Above Yest. High 🎈 Low Float 🎢 High Beta 🗓️ Earnings Next Week
Open $0.48
Prev Close $0.47
Day Range $0.48 โ€“ $0.53
52W Range $0.47 โ€“ $2.56
Market Cap $4.94M
Beta 2.13
EPS (TTM) $-0.34

๐Ÿ“‹ Company Profile

IndustryPharmaceuticals
CountryUS
ExchangeNYSE MKT LLC
CurrencyUSD
IPO Date2017-11-17
Shares Out.10,500,000
Websitecbdmd.com/ โ†—
Phone17044453060
Employees42
Revenue$5.6M
Gross Profit$3.3M
Net Income-$797,978
Free Cash Flow-$2.7M
Total Assets$12.3M
Total Liabilities$3.0M
Equity$9.3M
About cbdMD Inc

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

cbdMD Inc is a publicly traded company under the ticker symbol YCBD on the NYSE MKT LLC, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

๐Ÿ“Š Analyst Ratings

7 analysts (2026-07-01)

Strong Buy 2
Buy 4
Hold 1

๐Ÿ“ฐ Latest News for YCBD

๐Ÿ‘ฅ Related Stocks